Feasibility, reliability, and safety of remote five times sit to stand test in patients with gastrointestinal cancer

Daniel Steffens; Natasha C. Pocovi; Jenna Bartyn; Kim Delbaere; Mark J. Hancock; Cherry Koh; Linda Denehy; Kimberley S. van Schooten; Michael Solomon; on behalf of the Priority Trial Collaboration

doi:10.3390/cancers15092434

Feasibility, reliability, and safety of remote five times sit to stand test in patients with gastrointestinal cancer

Daniel Steffens^*, Natasha C. Pocovi, Jenna Bartyn, Kim Delbaere, Mark J. Hancock, Cherry Koh, Linda Denehy, Kimberley S. van Schooten, Michael Solomon, on behalf of the Priority Trial Collaboration

^*Corresponding author for this work

Department of Health Sciences

Research output: Contribution to journal › Article › peer-review

6 Citations (Scopus)

85 Downloads (Pure)

Abstract

Background: To determine the feasibility, reliability, and safety of the remote five times sit to stand test (5STS) test in patients with gastrointestinal cancer. Methods: Consecutive adult patients undergoing surgical treatment for lower gastrointestinal cancer at a major referral hospital in Sydney between July and November 2022 were included. Participants completed the 5STS test both face-to-face and remotely, with the order randomised. Outcomes included measures of feasibility, reliability, and safety. Results: Of fifty-five patients identified, seventeen (30.9%) were not interested, one (1.8%) had no internet coverage, and thirty-seven (67.3%) consented and completed both 5STS tests. The mean (SD) time taken to complete the face-to-face and remote 5STS tests was 9.1 (2.4) and 9.5 (2.3) seconds, respectively. Remote collection by telehealth was feasible, with only two participants (5.4%) having connectivity issues at the start of the remote assessment, but not interfering with the tests. The remote 5STS test showed excellent reliability (ICC = 0.957), with limits of agreement within acceptable ranges and no significant systematic errors observed. No adverse events were observed within either test environment. Conclusions: Remote 5STS for the assessment of functional lower extremity strength in gastrointestinal cancer patients is feasible, reliable, and safe, and can be used in clinical and research settings.

Original language	English
Article number	2434
Pages (from-to)	1-10
Number of pages	10
Journal	Cancers
Volume	15
Issue number	9
DOIs	https://doi.org/10.3390/cancers15092434
Publication status	Published - 24 Apr 2023

Bibliographical note

Copyright the Author(s) 2023. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.

Keywords

cancer
cross-sectional design
five times sit to stand test
reliability
remote assessment

Access to Document

10.3390/cancers15092434Licence: CC BY

Publisher version (open access)Final published version, 826 KBLicence: CC BY

Cite this

Steffens, D., Pocovi, N. C., Bartyn, J., Delbaere, K., Hancock, M. J., Koh, C., Denehy, L., van Schooten, K. S., Solomon, M., & on behalf of the Priority Trial Collaboration (2023). Feasibility, reliability, and safety of remote five times sit to stand test in patients with gastrointestinal cancer. Cancers, 15(9), 1-10. Article 2434. https://doi.org/10.3390/cancers15092434

@article{ad3d60b2052146a28da8ce86f4498da8,

title = "Feasibility, reliability, and safety of remote five times sit to stand test in patients with gastrointestinal cancer",

abstract = "Background: To determine the feasibility, reliability, and safety of the remote five times sit to stand test (5STS) test in patients with gastrointestinal cancer. Methods: Consecutive adult patients undergoing surgical treatment for lower gastrointestinal cancer at a major referral hospital in Sydney between July and November 2022 were included. Participants completed the 5STS test both face-to-face and remotely, with the order randomised. Outcomes included measures of feasibility, reliability, and safety. Results: Of fifty-five patients identified, seventeen (30.9%) were not interested, one (1.8%) had no internet coverage, and thirty-seven (67.3%) consented and completed both 5STS tests. The mean (SD) time taken to complete the face-to-face and remote 5STS tests was 9.1 (2.4) and 9.5 (2.3) seconds, respectively. Remote collection by telehealth was feasible, with only two participants (5.4%) having connectivity issues at the start of the remote assessment, but not interfering with the tests. The remote 5STS test showed excellent reliability (ICC = 0.957), with limits of agreement within acceptable ranges and no significant systematic errors observed. No adverse events were observed within either test environment. Conclusions: Remote 5STS for the assessment of functional lower extremity strength in gastrointestinal cancer patients is feasible, reliable, and safe, and can be used in clinical and research settings.",

keywords = "cancer, cross-sectional design, five times sit to stand test, reliability, remote assessment",

author = "Daniel Steffens and Pocovi, {Natasha C.} and Jenna Bartyn and Kim Delbaere and Hancock, {Mark J.} and Cherry Koh and Linda Denehy and {van Schooten}, {Kimberley S.} and Michael Solomon and {on behalf of the Priority Trial Collaboration}",

note = "Copyright the Author(s) 2023. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.",

year = "2023",

month = apr,

day = "24",

doi = "10.3390/cancers15092434",

language = "English",

volume = "15",

pages = "1--10",

journal = "Cancers",

issn = "2072-6694",

publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",

number = "9",

}

TY - JOUR

T1 - Feasibility, reliability, and safety of remote five times sit to stand test in patients with gastrointestinal cancer

AU - Steffens, Daniel

AU - Pocovi, Natasha C.

AU - Bartyn, Jenna

AU - Delbaere, Kim

AU - Hancock, Mark J.

AU - Koh, Cherry

AU - Denehy, Linda

AU - van Schooten, Kimberley S.

AU - Solomon, Michael

AU - on behalf of the Priority Trial Collaboration

N1 - Copyright the Author(s) 2023. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.

PY - 2023/4/24

Y1 - 2023/4/24

N2 - Background: To determine the feasibility, reliability, and safety of the remote five times sit to stand test (5STS) test in patients with gastrointestinal cancer. Methods: Consecutive adult patients undergoing surgical treatment for lower gastrointestinal cancer at a major referral hospital in Sydney between July and November 2022 were included. Participants completed the 5STS test both face-to-face and remotely, with the order randomised. Outcomes included measures of feasibility, reliability, and safety. Results: Of fifty-five patients identified, seventeen (30.9%) were not interested, one (1.8%) had no internet coverage, and thirty-seven (67.3%) consented and completed both 5STS tests. The mean (SD) time taken to complete the face-to-face and remote 5STS tests was 9.1 (2.4) and 9.5 (2.3) seconds, respectively. Remote collection by telehealth was feasible, with only two participants (5.4%) having connectivity issues at the start of the remote assessment, but not interfering with the tests. The remote 5STS test showed excellent reliability (ICC = 0.957), with limits of agreement within acceptable ranges and no significant systematic errors observed. No adverse events were observed within either test environment. Conclusions: Remote 5STS for the assessment of functional lower extremity strength in gastrointestinal cancer patients is feasible, reliable, and safe, and can be used in clinical and research settings.

AB - Background: To determine the feasibility, reliability, and safety of the remote five times sit to stand test (5STS) test in patients with gastrointestinal cancer. Methods: Consecutive adult patients undergoing surgical treatment for lower gastrointestinal cancer at a major referral hospital in Sydney between July and November 2022 were included. Participants completed the 5STS test both face-to-face and remotely, with the order randomised. Outcomes included measures of feasibility, reliability, and safety. Results: Of fifty-five patients identified, seventeen (30.9%) were not interested, one (1.8%) had no internet coverage, and thirty-seven (67.3%) consented and completed both 5STS tests. The mean (SD) time taken to complete the face-to-face and remote 5STS tests was 9.1 (2.4) and 9.5 (2.3) seconds, respectively. Remote collection by telehealth was feasible, with only two participants (5.4%) having connectivity issues at the start of the remote assessment, but not interfering with the tests. The remote 5STS test showed excellent reliability (ICC = 0.957), with limits of agreement within acceptable ranges and no significant systematic errors observed. No adverse events were observed within either test environment. Conclusions: Remote 5STS for the assessment of functional lower extremity strength in gastrointestinal cancer patients is feasible, reliable, and safe, and can be used in clinical and research settings.

KW - cancer

KW - cross-sectional design

KW - five times sit to stand test

KW - reliability

KW - remote assessment

UR - http://www.scopus.com/inward/record.url?scp=85159586226&partnerID=8YFLogxK

U2 - 10.3390/cancers15092434

DO - 10.3390/cancers15092434

M3 - Article

C2 - 37173899

AN - SCOPUS:85159586226

SN - 2072-6694

VL - 15

SP - 1

EP - 10

JO - Cancers

JF - Cancers

IS - 9

M1 - 2434

ER -

Feasibility, reliability, and safety of remote five times sit to stand test in patients with gastrointestinal cancer

Abstract

Bibliographical note

Keywords

Access to Document

Other files and links

Fingerprint

Cite this